Catalys Pacific — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Exalys TherapeuticsApr 2020SEC filinghigh confidence
BiotechSan Diego, US
Eckard Weber, M.D.(Director)Michael Sanders(Executive Officer)Nicole Vitullo(Director)Dennis Podlesak(Executive Officer, Director)Rick Orr(Director)Lynne Rollins(Executive Officer)
Board seatTakeshi TakahashiBrian Taylor Slingsby· per SEC Form D · $25M raise · filed Apr 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.